Cannabis Bioscience International Holdings (CBIH) EBIAT (2022 - 2026)
Cannabis Bioscience International Holdings filings provide 5 years of EBIAT readings, the most recent being -$103933.0 for Q1 2026.
- On a quarterly basis, EBIAT rose 42.66% to -$103933.0 in Q1 2026 year-over-year; TTM through Feb 2026 was -$515288.0, a 8.94% decrease, with the full-year FY2025 number at -$548820.0, up 15.74% from a year prior.
- EBIAT reached -$103933.0 in Q1 2026 per CBIH's latest filing, up from -$116966.0 in the prior quarter.
- The five-year high for EBIAT was -$76305.0 in Q3 2024, with the low at -$324655.0 in Q1 2023.
- A 5-year average of -$166018.2 and a median of -$158589.0 in 2024 define the central range for EBIAT.
- Year-over-year, EBIAT soared 58.03% in 2024 and then tumbled 55.77% in 2025.
- Year by year, EBIAT stood at -$219886.0 in 2022, then soared by 43.41% to -$124426.0 in 2023, then surged by 36.08% to -$79528.0 in 2024, then tumbled by 47.08% to -$116966.0 in 2025, then grew by 11.14% to -$103933.0 in 2026.
- Per Business Quant, the three most recent readings for CBIH's EBIAT are -$103933.0 (Q1 2026), -$116966.0 (Q4 2025), and -$82645.0 (Q3 2025).